AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 107 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,013,800 | -42.5% | 2,510,000 | 0.0% | 0.25% | -33.9% |
| Q2 2023 | $27,835,900 | -27.8% | 2,510,000 | 0.0% | 0.38% | -33.8% |
| Q1 2023 | $38,528,500 | -15.3% | 2,510,000 | +22.4% | 0.57% | -16.0% |
| Q4 2022 | $45,489,500 | +92.1% | 2,050,000 | +41.4% | 0.68% | +55.6% |
| Q3 2022 | $23,679,000 | +25.4% | 1,450,000 | +11.5% | 0.44% | +17.2% |
| Q2 2022 | $18,889,000 | -21.3% | 1,300,000 | 0.0% | 0.37% | -14.8% |
| Q1 2022 | $24,011,000 | -17.9% | 1,300,000 | +5.7% | 0.44% | -12.0% |
| Q4 2021 | $29,237,000 | +3.2% | 1,230,000 | +7.0% | 0.50% | +11.9% |
| Q3 2021 | $28,325,000 | +110.3% | 1,150,000 | +111.0% | 0.44% | +90.2% |
| Q2 2021 | $13,467,000 | +13.3% | 545,000 | 0.0% | 0.23% | +14.1% |
| Q1 2021 | $11,886,000 | -14.5% | 545,000 | 0.0% | 0.20% | -14.6% |
| Q4 2020 | $13,908,000 | -9.3% | 545,000 | 0.0% | 0.24% | +10.1% |
| Q3 2020 | $15,342,000 | -7.2% | 545,000 | -6.8% | 0.22% | -33.3% |
| Q2 2020 | $16,532,000 | – | 585,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |